Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?

By Neldam Steen  

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 129-135

Future Medicine

Access to resources Recommend Favorite

Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation

By Isobe Aki   Takeda Takashi   Sakata Masahiro   Miyake Asako   Yamamoto Toshiya   Minekawa Ryoko   Nishimoto Fumihito   Oskamoto Yoko   Walker Cheryl Lyn   Kimura Tadashi  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 440-446

Oxford University Press

Access to resources Recommend Favorite

A Novel Molecule of the Angiotensin II Receptor Blocker Class: Focus on Olmesartan Medoxomil

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 79-89

Adis International

Access to resources Recommend Favorite

Effects of Angiotensin II Receptor Blockers on the Relationships Between Ambulatory Blood Pressure and Anti-Hypertensive Effects, Autonomic Function, and Health-Related Quality of Life

By Okano Yasuko   Tamura Kouichi   Masuda Shinitirou   Ozawa Motoko   Tochikubo Osamu   Umemura Satoshi  

Clinical and Experimental Hypertension, Vol. 31, Iss. 8, 2009-12 ,pp. : 680-689

Informa Healthcare

Access to resources Recommend Favorite

Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients

By Rodríguez-Pérez José C.   García-Bello Miguel A.   Anabitarte-Prieto Aránzazu   Companioni Osmel   Nóvoa-Mogollón Francisco J.   Suárez-Ortega Saturnino   Plaza-Toledano Celia   Rodríguez-Esparragón Francisco  

Clinical and Experimental Hypertension, Vol. 33, Iss. 8, 2011-12 ,pp. : 506-510

Informa Healthcare

Access to resources Recommend Favorite